These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28754892)

  • 21. High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.
    Marino F; Chong C; Michaux J; Bassani-Sternberg M
    Methods Mol Biol; 2019; 1913():67-79. PubMed ID: 30666599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.
    Kampstra AS; van Heemst J; Moustakas AK; Papadopoulos GK; Huizinga TW; Toes RE
    Arthritis Res Ther; 2016 Nov; 18(1):254. PubMed ID: 27809896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.
    Wang Q; Drouin EE; Yao C; Zhang J; Huang Y; Leon DR; Steere AC; Costello CE
    J Proteome Res; 2017 Jan; 16(1):122-136. PubMed ID: 27726376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.
    van Heemst J; Jansen DT; Polydorides S; Moustakas AK; Bax M; Feitsma AL; Bontrop-Elferink DG; Baarse M; van der Woude D; Wolbink GJ; Rispens T; Koning F; de Vries RR; Papadopoulos GK; Archontis G; Huizinga TW; Toes RE
    Nat Commun; 2015 May; 6():6681. PubMed ID: 25942574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
    Hansen BE; Andersson EC; Madsen LS; Engberg J; Søndergaard L; Svejgaard A; Fugger L
    Tissue Antigens; 1998 Feb; 51(2):119-28. PubMed ID: 9510368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An HLA-binding-motif-aided peptide epitope library: a novel library design for the screening of HLA-DR4-restricted antigenic peptides recognized by CD4+T cells.
    Tana T; Kamikawaji N; Savoie CJ; Sudo T; Kinoshita Y; Sasazuki T
    J Hum Genet; 1998; 43(1):14-21. PubMed ID: 9609993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires.
    Scholz EM; Marcilla M; Daura X; Arribas-Layton D; James EA; Alvarez I
    Front Immunol; 2017; 8():984. PubMed ID: 28871256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of autoimmune diseases through manipulation of antigen presentation.
    Spack EG
    Crit Rev Immunol; 1997; 17(5-6):529-36. PubMed ID: 9419440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional HLA-DM on the surface of B cells and immature dendritic cells.
    Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
    EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
    Cai W; Zhou D; Wu W; Tan WL; Wang J; Zhou C; Lou Y
    BMC Genomics; 2018 Aug; 19(1):582. PubMed ID: 30075702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
    Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
    J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis: Skin-induced antigen-specific immune tolerance.
    Wildner P; Selmaj KW
    J Neuroimmunol; 2017 Oct; 311():49-58. PubMed ID: 28803660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.
    Vitulano C; Tedeschi V; Paladini F; Sorrentino R; Fiorillo MT
    Clin Exp Immunol; 2017 Dec; 190(3):281-290. PubMed ID: 28759104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins.
    Lindsey JW
    J Neuroimmunol; 2017 Sep; 310():131-134. PubMed ID: 28778437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APP mouse models for Alzheimer's disease preclinical studies.
    Sasaguri H; Nilsson P; Hashimoto S; Nagata K; Saito T; De Strooper B; Hardy J; Vassar R; Winblad B; Saido TC
    EMBO J; 2017 Sep; 36(17):2473-2487. PubMed ID: 28768718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
    Hrastelj J; Robertson N
    J Neurol; 2017 Sep; 264(9):2040-2042. PubMed ID: 28785799
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
    Zhu B; Nestorov I; Zhao G; Meka V; Leahy M; Kam J; Sheikh SI
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):604-613. PubMed ID: 28783872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.